Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|April 17, 2022
Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatmentFlorian E Buisman, Daniele Giardiello, Nancy E Kemeny, et al.
The Journal of Pathology|November 19, 2016
Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis modelsVictoria L Bridgeman, Peter B Vermeulen, Shane Foo, et al.
Clinical & Experimental Metastasis|July 22, 2020
Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastasesFlorian E Buisman, Eric P van der Stok, Boris Galjart, et al.
Cancer Research|March 29, 2022
Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine TreatmentMarina Roy-Luzarraga, Louise E Reynolds, Beatriz de Luxán-Delgado, et al.
Current Biology : CB|March 8, 2016
The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and AngiogenesisCassie J Clarke, Tracy J Berg, Joanna Birch, et al.
British Journal of Cancer|July 23, 2025
The colorectal liver metastasis growth pattern phenotype is not dependent on genotypeDiederik J Höppener, Sanne M L Verheul, Pieter M H Nierop, et al.
Nature Communications|August 18, 2023
An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liverCarlos Fernández Moro, Natalie Geyer, Sara Harrizi, et al.
JNCI Cancer Spectrum|May 31, 2021
Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation StudyDiederik J Höppener, Boris Galjart, Pieter M H Nierop, et al.
Nature Genetics|February 10, 2025
Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancerSlim Mzoughi, Megan Schwarz, Xuedi Wang, et al.
Molecular Oncology|March 16, 2015
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced diseaseMaurice P H M Jansen, Leen Sas, Anieta M Sieuwerts, et al.
Pageof 9